Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan
Authors:
- Muneeba Ahsan SayeedMSMuneeba Ahsan Sayeed
- Elisha ShalimESElisha Shalim
- Fizza FarooquiFFFizza Farooqui
- Shaiza FarmanSFShaiza Farman
- Maheen KhanMKMaheen Khan
- Anika IqbalAIAnika Iqbal
- Ishfaque AhmedIAIshfaque Ahmed
- Abdul Wahid RajputARAbdul Wahid Rajput
- Abdul RazzaqueARAbdul Razzaque
- Saeed QuraishySQSaeed Quraishy
Open Access
Abstract
We compared the clinical characteristics and outcome of vaccinated hospitalized COVID-19 patients with unvaccinated hospitalized COVID-19 patients. A retrospective cohort study was conducted at the Sindh Infectious Diseases Hospital and Research Center, Karachi, Pakistan. A total of 1407 hospitalized COVID-19 positive patients were included from April 2021 to March 2022, of which 812 (57.71%) were males. Of the 1407, 378 (26.87%) patients were vaccinated while 1029 (73.13%) were unvaccinated. Of the vaccinated patients, 160 (42.32%) were partially vaccinated while 218 (57.68%) were fully vaccinated (vaccine breakthrough infection). Fewer unvaccinated COVID-19 patients survived compared to vaccinated patients (62.5% vs. 70%, RR 0.89, 95% CI: 0.82–0.96, p-value = 0.004). Despite there being more vaccinated patients above 60 years of age (60.05% vs. 47.13%), their risk of mortality was lower by 43% (OR = 0.578; CI = 0.4201 to 0.7980, p = 0.0009). On survival analysis, vaccinated patients had better 30-day survival compared to unvaccinated patients (p = 0.028). Moreover, comparing waves 3–5, unvaccinated patients of wave 4, which was driven by the delta variant, had the worst survival (51.8%, p ≤ 0.001) while vaccinated patients of wave 3 (driven by the alpha variant) had the best survival (71.6%).Keywords
This publication has 23 references indexed in Scilit:
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Determinants of in-hospital mortality in COVID-19; a prospective cohort study from PakistanPLOS ONE, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort studyThe Lancet, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021
- Clinical Characteristics and Outcome of Patients With Severe COVID-19 Pneumonia at a Public Sector Hospital in Karachi, PakistanCureus, 2021
- Determinants of in-hospital mortality in COVID-19; a prospective cohort study from PakistanmedRxiv, 2021
- COVID-19 and diabetes: What does the clinician need to know?Primary Care Diabetes, 2020
- A brief-review of the risk factors for covid-19 severityRevista de Saúde Pública, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020